Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Vaccine , 2012;30:350–360. doi: 10.1016/j.vaccine.2011.10.086.